Literature DB >> 1692613

A cDNA clone closely associated with non-A, non-B hepatitis.

M Maéno1, K Kaminaka, H Sugimoto, M Esumi, N Hayashi, K Komatsu, K Abe, S Sekiguchi, M Yano, K Mizuno.   

Abstract

A lambda gt11 cDNA library was constructed from RNA purified from hepatitis B viral surface antigen-negative human plasma with high alanine aminotransferase activity. A cDNA clone, designated as C8-2, was isolated by immunoscreening with mixed sera from non-A, non-B hepatitis (NANBH) carrier and convalescent chimpanzees. The recombinant protein produced by C8-2 reacted specifically with sera of patients in the chronic phase of NANBH. The sequence of C8-2, 269 bp, did not hybridized with any human or chimpanzee genomic DNA, and had no homology with those of primates and viruses. The existence of this sequence in RNA of possibly infectious plasma was shown by RNA blot hybridization and by Southern blot analysis of products amplified by the polymerase chain reaction. These results strongly suggest that C8-2 is derived from the agent of this viral hepatitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692613      PMCID: PMC330752          DOI: 10.1093/nar/18.9.2685

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  13 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Polymerase chain reaction amplification of rhinovirus nucleic acids from clinical material.

Authors:  R E Gama; P J Hughes; C B Bruce; G Stanway
Journal:  Nucleic Acids Res       Date:  1988-10-11       Impact factor: 16.971

3.  Lambda gt 11: gene isolation with antibody probes and other applications.

Authors:  M Snyder; S Elledge; D Sweetser; R A Young; R W Davis
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Prediction of protein antigenic determinants from amino acid sequences.

Authors:  T P Hopp; K R Woods
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

Review 5.  non-A, Non-B hepatitis. II. Experimental transmission, putative virus agents and markers, and prevention.

Authors:  J L Dienstag
Journal:  Gastroenterology       Date:  1983-09       Impact factor: 22.682

6.  Production of antibody associated with non-A, non-B hepatitis in a chimpanzee lymphoblastoid cell line established by in vitro transformation with Epstein-Barr virus.

Authors:  Y K Shimizu; M Oomura; K Abe; M Uno; E Yamada; Y Ono; T Shikata
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

7.  Cloning of a cDNA associated with acute and chronic hepatitis C infection generated from patients serum RNA.

Authors:  T Arima; H Nagashima; S Murakami; C Kaji; J Fujita; H Shimomura; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1989-10

8.  A lambda gt11-cDNA clone specific for chronic hepatitis C generated from pooled serum presumably infected by hepatitis C virus.

Authors:  T Arima; A Takamizawa; C Mori; S Murakami; C Kaji; J Fujita
Journal:  Gastroenterol Jpn       Date:  1989-10

9.  Isolation of a virus from chimpanzee liver cell cultures inoculated with sera containing the agent of non-A, non-B hepatitis.

Authors:  A M Prince; T Huima; B A Williams; L Bardina; B Brotman
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  13 in total

1.  Discrimination of hepatitis C virus in liver tissues from different patients with hepatocellular carcinomas by direct nucleotide sequencing of amplified cDNA of the viral genome.

Authors:  W H Chou; T Yoneyama; K Takeuchi; H Harada; I Saito; T Miyamura
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

2.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

Authors:  N Kato; M Hijikata; Y Ootsuyama; M Nakagawa; S Ohkoshi; T Sugimura; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Nucleotide sequence and mutation rate of the H strain of hepatitis C virus.

Authors:  N Ogata; H J Alter; R H Miller; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  Structure and organization of the hepatitis C virus genome isolated from human carriers.

Authors:  A Takamizawa; C Mori; I Fuke; S Manabe; S Murakami; J Fujita; E Onishi; T Andoh; I Yoshida; H Okayama
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

5.  Clinical course of acute hepatitis C and changes in HCV markers.

Authors:  K Hino; S Sainokami; K Shimoda; H Niwa; S Iino
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

6.  Evaluation of three hepatitis C virus-related antibodies C100, KCL-163, JCC. Tests for screening blood donors.

Authors:  S Fujiyama; S Kawano; S Sato; T Sato; T Kawahara; K Mizuno; Y Kusumoto; M Esumi; T Shikata
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

7.  Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates.

Authors:  G Inchauspe; S Zebedee; D H Lee; M Sugitani; M Nasoff; A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

8.  Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein.

Authors:  M Shirai; T Akatsuka; C D Pendleton; R Houghten; C Wychowski; K Mihalik; S Feinstone; J A Berzofsky
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

9.  Identification of hepatitis C viruses with a nonconserved sequence of the 5' untranslated region.

Authors:  C H Lee; C Cheng; J Wang; L Lumeng
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

10.  Detection of hepatitis C virus RNA in patients with chronic hepatitis C virus infections during and after therapy with alpha interferon.

Authors:  G E Kleter; J T Brouwer; R A Heijtink; S W Schalm; W G Quint
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.